Top

Published in:

01-10-2014 | Media release

Naloxegol approved for opioid-induced constipation

Published in: Reactions Weekly | Issue 1/2014

Excerpt

The US FDA has approved naloxegol (MOVANTIK) for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, according to an AstraZeneca media release. It is expected to be available to patients in the first half of 2015. …

AstraZeneca. FDA Approves MOVANTIK(Tm) (naloxegol) Tablets C-II for the Treatment of Opioid-Induced Constipation in Adult Patients with Chronic Non-Cancer Pain. Media Release : 16 Sep 2014. Available from: URL: http://www.astrazeneca-us.com

Title: Naloxegol approved for opioid-induced constipation
Publication date: 01-10-2014
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2014
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-014-3808-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Naloxegol approved for opioid-induced constipation

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2014

Sorafenib

Metformin may lower TSH levels

Disulfiram

Azathioprine/prednisone

Imatinib

Amoxicillin/amoxicillin/clavulanic-acid